Press release
Mixed Mode Chromatography Resin Market Size Estimated to Reach US$ 743 Million at a CAGR of 15.7% by 2035
Mixed Mode Chromatography Resin Market
These resins utilize multimodal ligands, allowing for protein binding through a combination of ionic interactions, hydrogen bonding, and hydrophobic forces. This multifaceted binding mechanism offers superior selectivity, resolution, and loading capacity compared to traditional single-mode chromatography systems. The year 2024 marked a pivotal phase for the industry, driven by increasing demand for advanced separation technologies, particularly in the pharmaceutical and biotechnology sectors. Innovations in resin chemistry and growing bioprocessing applications have elevated the importance of mixed mode chromatography in areas such as monoclonal antibody purification, vaccines, and gene therapies. The market is set to gain further momentum as regulatory expectations and efficiency standards continue to rise in bioseparation processes.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7451
Country-Wise Analysis
The United States remains at the forefront of biopharmaceutical innovation, making it the most influential market for mixed mode chromatography resins. Its well-established R&D ecosystem, combined with the presence of leading biologics manufacturers, consistently drives demand for advanced purification technologies that support complex biologics production.
In India, the biopharmaceutical sector is rapidly expanding, fueled by cost-effective manufacturing capabilities and a growing clinical research environment. National initiatives such as "Make in India" and strategic support for biosimilar development have catalyzed infrastructure growth across biotech hubs, creating a strong foundation for increased adoption of mixed mode chromatography technologies.
China is also emerging as a dominant global force in biopharma, with substantial public and private investments directed toward biologics R&D. Government programs like "Healthy China 2030" are accelerating innovation in drug manufacturing, encouraging widespread uptake of modern purification solutions such as mixed mode chromatography resins.
The United Kingdom benefits from a strong academic research base and a vibrant biotech startup ecosystem, both of which contribute to consistent demand. As the country pushes further into personalized medicine and small-batch biologics, the need for high-efficiency, flexible purification methods is steadily growing, bolstering the mixed mode chromatography resins market.
Key Industry Players
Thermo Fisher Scientific
Cytiva (Danaher Corporation)
Merck KGaA (MilliporeSigma)
Agilent Technologies
Bio-Rad Laboratories, Inc.
Tosoh Corporation
GE Healthcare (now part of Cytiva in chromatography)
Purolite Corporation
Avantor (including VWR & Pall acquisitions)
JSR Micro Inc.
Kaneka Corporation
Sepragen Corporation
Repligen Corporation
Bio-Works Technologies
Competitive Landscape
The mixed-mode chromatography resin market is moderately concentrated, with key players such as Merck KGaA, Bio-Rad Laboratories, and Tosoh Corporation holding significant market shares. These companies actively compete through strategies centered on innovation, strategic collaborations, and capacity expansions to meet the rising demand for advanced purification solutions in biopharmaceutical manufacturing.
In 2024, Merck KGaA announced the expansion of its chromatography resin production capabilities. This move aims to support increasing global demand for high-performance resins used in the purification of monoclonal antibodies and other complex biologics, reflecting the growing scale and complexity of biopharma production pipelines.
Also in 2024, Bio-Rad Laboratories introduced a new line of high-performance ion-exchange chromatography resins tailored specifically for the biopharmaceutical industry. These resins are designed to deliver enhanced binding capacity and selectivity, addressing the escalating need for efficient protein purification technologies in biologics development.
Meanwhile, Tosoh Corporation continues to strengthen its position through R&D initiatives and quality-focused manufacturing, supporting global clients across biologics and biosimilar production. Collectively, these advancements highlight the sector's push toward greater efficiency, scalability, and process optimization in bioprocessing.
Browse Full Report: https://www.factmr.com/report/mixed-mode-chromatography-resin-market
Segmentation
By Type:
Ion Exchange-Hydrophobic Type
Hydroxyapatite Type
Others
By Application:
Antibodies Production
Vaccine Production
Non-antibody Proteins
Antibody-drug conjugate
Separation of low molecular weight impurities
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Check out More Related Studies Published by Fact.MR:
Genu Recurvatum Market
https://www.factmr.com/report/genu-recurvatum-market
Hemianopsia Market
https://www.factmr.com/report/hemianopsia-market
Chronic Idiopathic Constipation Treatment Market
https://www.factmr.com/report/chronic-idiopathic-constipation-treatment-market
Grand Mal Seizure Treatment Market
https://www.factmr.com/report/grand-mal-seizure-treatment-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mixed Mode Chromatography Resin Market Size Estimated to Reach US$ 743 Million at a CAGR of 15.7% by 2035 here
News-ID: 4084197 • Views: …
More Releases from Fact.MR
Vitrectomy Machines Market is Predicted to Reach US$ 1,051.2 Million by 2035, Ex …
The global vitrectomy machines market is expected to witness significant growth, reaching an estimated USD 528.5 million by 2025 and projected to nearly double to around USD 1,051.2 million by 2035, registering a CAGR of approximately 7.2%. This expansion is largely driven by the rising elderly population and continuous advancements in ophthalmic surgical technologies.
A key factor fueling this market is the growing prevalence of retinal disorders such as diabetic retinopathy,…
Skincare Consultation Platform Market is Predicted to Reach at USD 13,687 Millio …
The global skincare consultation platform market is on a dynamic growth trajectory, projected to soar from USD 3,722 million in 2024 to USD 13,687 million by 2035, according to a comprehensive report by Fact.MR. With a robust compound annual growth rate (CAGR) of 12.5% over the forecast period from 2025 to 2035, the market is expected to grow 3.2X, creating an absolute dollar opportunity of USD 9,472 million. Fueled by…
Hyperdispersants Market is Forecasted To Reach USD 3,842 Million By 2035 | Fact. …
The global hyperdispersants market is set for steady growth, projected to rise from USD 2,200 million in 2024 to USD 3,842 million by 2035, according to a comprehensive report by Fact.MR. With a compound annual growth rate (CAGR) of 5.2% over the forecast period from 2025 to 2035, the market is expected to grow 1.6X, creating an absolute dollar opportunity of USD 1,528 million. The surge is driven by increasing…
Reduced Risk Products Market is Expanding From An Estimated $31.5 Bn In 2025 | F …
The global reduced risk products (RRP) market is poised for significant growth, projected to rise from USD 29.2 billion in 2024 to an impressive USD 71.2 billion by 2035, according to a comprehensive report by Fact.MR. With a robust compound annual growth rate (CAGR) of 8.5% over the forecast period from 2025 to 2035, the market is expected to grow 2.4X, unlocking an absolute dollar opportunity of USD 40 billion.…
More Releases for Corporation
Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S …
A fresh report titled “Endotherapy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report.
The global endotherapy devices market is projected to reach…
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
Smart Camera Market || Key Players - Samsung Electronics Co., Canon Inc., Nikon …
Looking at the current market trends as well as the promising demand status of the Smart Camera Market, it can be projected that the future years will bring out positive outcomes. This research report added by MRRSE on its online portal delivers clear insight about the changing tendencies across the global Smart Camera Market. Readers can gather prime facets connected to the target market which includes product, end-use and application;…
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor …
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally.
Introduction
Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’.
Get PDF for more Professional and Technical insights…
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, …
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing at…
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif …
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices market…
